1. Home
  2. BNTC vs AUDC Comparison

BNTC vs AUDC Comparison

Compare BNTC & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • AUDC
  • Stock Information
  • Founded
  • BNTC 1995
  • AUDC 1992
  • Country
  • BNTC United States
  • AUDC Israel
  • Employees
  • BNTC N/A
  • AUDC N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • AUDC Telecommunications Equipment
  • Sector
  • BNTC Health Care
  • AUDC Utilities
  • Exchange
  • BNTC Nasdaq
  • AUDC Nasdaq
  • Market Cap
  • BNTC 339.8M
  • AUDC 299.7M
  • IPO Year
  • BNTC N/A
  • AUDC 1999
  • Fundamental
  • Price
  • BNTC $16.49
  • AUDC $9.90
  • Analyst Decision
  • BNTC Strong Buy
  • AUDC Buy
  • Analyst Count
  • BNTC 7
  • AUDC 2
  • Target Price
  • BNTC $24.43
  • AUDC $11.25
  • AVG Volume (30 Days)
  • BNTC 37.6K
  • AUDC 78.0K
  • Earning Date
  • BNTC 05-12-2025
  • AUDC 05-06-2025
  • Dividend Yield
  • BNTC N/A
  • AUDC 1.77%
  • EPS Growth
  • BNTC N/A
  • AUDC 78.82
  • EPS
  • BNTC N/A
  • AUDC 0.50
  • Revenue
  • BNTC N/A
  • AUDC $242,176,000.00
  • Revenue This Year
  • BNTC N/A
  • AUDC $5.11
  • Revenue Next Year
  • BNTC N/A
  • AUDC $3.79
  • P/E Ratio
  • BNTC N/A
  • AUDC $20.42
  • Revenue Growth
  • BNTC N/A
  • AUDC N/A
  • 52 Week Low
  • BNTC $4.75
  • AUDC $7.70
  • 52 Week High
  • BNTC $15.97
  • AUDC $13.71
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 66.94
  • AUDC 37.28
  • Support Level
  • BNTC $14.90
  • AUDC $10.08
  • Resistance Level
  • BNTC $15.97
  • AUDC $10.69
  • Average True Range (ATR)
  • BNTC 1.03
  • AUDC 0.31
  • MACD
  • BNTC 0.30
  • AUDC -0.06
  • Stochastic Oscillator
  • BNTC 79.02
  • AUDC 18.53

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About AUDC AudioCodes Ltd.

AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.

Share on Social Networks: